triazoles has been researched along with 1,2,3,4-tetrahydroisoquinoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghaleb, H; Huang, W; Jiang, C; Kairuki, M; Li, Q; Pan, M; Qian, H; Qiu, Q; Zhou, J | 1 |
1 other study(ies) available for triazoles and 1,2,3,4-tetrahydroisoquinoline
Article | Year |
---|---|
Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Design; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Humans; K562 Cells; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Tetrahydroisoquinolines; Triazoles | 2019 |